U.S. market Closed. Opens in 17 hours 12 minutes

VRNA | Verona Pharma plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312020-12-312019-12-312018-12-312017-12-302016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
RevenueN/A458.00K458.00K458.00K40.00M40.00MN/A2.35K2.78KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue679.62KN/A346.00K346.00KN/AN/A627.85K512.11KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-679.62K458.00K112.00K112.00K40.00M40.00M-627.85K-509.76K2.78KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses67.15M62.77M66.23M66.23M97.68M97.68M66.01M53.41M32.48M-40.26M8.49M13.29M5.90M4.64M4.18M2.86M2.90M2.59M2.17M2.59M1.31M12.04K
Selling, General & Admin49.87M43.70M26.58M26.58M33.91M33.91M29.77M8.99M7.99M-8.17M1.62M1.36M1.80M1.91M1.47M1.12M1.09M1.05M827.39K894.40K1.05M18.93K
Research & Development17.28M19.93M49.28M49.28M79.41M79.41M44.51M43.89M24.48M-32.09M5.58M10.76M4.10M2.73M2.71M1.46M1.78M1.53M1.29M1.50M266.45KN/A
Other Operating ExpensesN/AN/A-9.63M-9.63M-15.63M-15.63M-8.27M527.09K16.50KN/A1.29M1.17MN/AN/A0268.60K43.22K11.32K61.51K196.33KN/A-6.88K
Operating Income-67.83M-63.52M-66.12M-66.12M-73.31M-73.31M-74.28M-53.87M-32.47M-40.21M-8.49M-13.29M-5.90M-4.64M-4.18M-2.86M-2.90M-2.59M-2.17M-2.59M-1.31M-12.04K
Other Expenses / Income12.62M2.86M-2.33M-2.33M17.73M17.73M9.28M2.46M1.85MN/A1.12M66.36K46.66K4.34K32.61K-6.21K-9.26K1.62K207.94K176.50K123.43K56.78K
Before Tax Income-55.21M-50.13M-68.45M-68.45M-55.59M-55.59M-65.00M-51.41M-30.62MN/A-7.37M-13.22M-5.86M-4.64M-4.15M-2.86M-2.91M-2.59M-1.97M-2.41M-1.19M44.74K
Income Tax Expenses-632.44K555.00K253.00K253.00K-18.00K-18.00K146.00K-9.53M-5.37MN/A-1.18M-2.24M-1.56M-477.22K-77.68K-192.52K7.72KN/A41.00KN/AN/AN/A
Net Income-54.58M-50.69M-68.70M-68.70M-55.57M-55.57M-65.15M-41.88M-25.25MN/A-6.19M-10.99M-4.29M-4.16M-4.07M-2.67M-2.92M-2.59M-2.01M-2.41M-1.19M44.74K
Interest Expenses2.06M1.66M521.00K521.00K340.00K340.00K35.00K221.59KN/A98.65K104.52KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding79.27MN/A591.49M66.13M591.49M59.15M32.87M13.17M131.39M10.97M209.37M126.24M108.34M42.70M38.33M30.43M29.85M26.94M26.14M18.05M9.66M5.59M
Diluted Shares Outstanding79.27MN/A591.49M66.13M591.49M59.15M32.87M13.17M131.39M10.97M209.37M126.24M108.34M42.70M38.33M30.43M29.85M26.94M26.14M18.05M9.66M6.83M
EBITDA-67.15M-50.71M-62.66M-62.66M-57.04M-57.04M-65.27M-51.76M-31.27M7.00K-8.50M-13.21M-5.82M-4.58M-4.13M-2.82M-2.87M-2.55M-2.15M-2.56M-1.31M-12.04K
EBITDA Margin0.00%-11,071.40%-13,681.00%-13,681.00%-142.60%-142.60%0.00%-2,201,821.75%-1,123,504.50%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-53.15M-48.47M-67.93M-67.93M-55.25M-55.25M-64.97M-51.18M-30.62M98.65K-7.26M-13.22M-5.86M-4.64M-4.15M-2.86M-2.91M-2.59M-1.97M-2.41M-1.19M44.74K
EBIT Margin0.00%-10,582.75%-14,831.22%-14,831.22%-138.12%-138.12%0.00%-2,177,115.39%-1,100,342.28%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312020-12-312019-12-312018-12-312017-12-302016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙